<!DOCTYPE html>
<html>

<head>
    <title>Page 105</title>
</head>

<body>

    <h4 style="color: blue;">Available Cerftriaxone Products:</h4>
    <ul>
        <li>Cerftriaxone 250mg I.M.</li>
        <li>Cerftriaxone 500mg I.M. & I.V</li>
        <li>Cerftriaxone 1000mg I.M. & I.V</li>
    </ul>

    <img src="products.png" style="width: 100%;"/>

    <h4 style="color: blue; text-decoration: underline; margin: 0;">Method of administration</h4>
    <h4 style="color: #509c3b; text-decoration: underline; margin: 0">I.M. injections:</h4>
    <ul>
        <li>Intramuscular administration should be considered when the
            intravenous route is not possible or less appcropriate for the patient</li>
        <li>Dosages >1 g should be divided and
            injected at more than one site.</li>
        <li>As the solvent used is lidocaine, the
            resulting solution should never be</li>
        <li>The maximum single dose of lidocaine
            in children should not exceed 5 mg/kg
            body weight</li>
        <li>For obese children, the maximum dose
            should be calculated based on ideal
            bodyweight for their gender and age.</li>

    </ul>

    <h4 style="color: #509c3b; text-decoration: underline; margin: 0">I.V. injections:</h4>

    <ul>
        <li>For doses greater than 2 g
            intravenous administration should
            be used.</li>
        <li>Ceftriaxone can be administered by:
        </li>
    </ul>
    <ul style="list-style: none;">
        <li>o Intravenous infusion over at least
            30 minutes (preferred route) or
        </li>
        <li>o Slow intravenous injection over 5
            minutes preferably in larger
            veins</li>
    </ul>

    <ul>
        <li>Intravenous doses of 50 mg/kg or
            more in infants and children up to
            12 years of age should be given by
            infusion.</li>
        <li>Intravenous infusion: Ceftriaxone should
            be dissolved in one of the following
            calcium-free infusion solutions: [Sodium
            chloride 0.9%, 0.45% or glucose 2.5%, 5
            % 10%].</li>
        <li>Avoid mixing or reconstitution of
            Ceftriaxone with calcium-containing
            diluents (e.g. Ringer’s solution or
            Hartmann’s solution) because a
            precipitate can form.</li>
        <li>Ceftriaxone is contraindicated in
            neonates (≤ 28 days) if they require (or
            are expected to require) treatment with
            calcium-containing intravenous solutions
            including continuous calcium containing
            infusions such as parenteral nutrition,
            because of the risk of precipitation.</li>
    </ul>

</body>

</html>